Nachrichten zur Merck KGaA Aktie

Jim Cramer says he supports healthcare stocks for their long-term value

CNBCs Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and Regeneron.…

Digital Neuro Biomarkers Market Research 2025-2030, Competitive Analysis of Altoida, Koneksa, Biogen, Roche, NeuraMetrix, Merck, Linus Health, Neurotrack Technologies, Huma, and NeuraLight

The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population…

Meet the 15 Dow Jones Stocks That Combined for Over $150 Billion in Dividends in 2024 and Will All Likely Boost Their Payouts Again in 2025

The Dow Jones Industrial Average (DJINDICES: ^DJI) is composed of 30 industry-leading blue-chip businesses that represent the broader market. Many…

Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer

The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand…

Merck Buy

NEW YORK (dpa-AFX Analyser) - Goldman Sachs hat das Kursziel für Merck KGaA von 196 auf 185 Euro gesenkt, aber…

Goldman senkt Ziel für Merck KGaA auf 185 Euro - Buy

NEW YORK (dpa-AFX Analyser) - Goldman Sachs hat das Kursziel für Merck KGaA von 196 auf 185 Euro gesenkt, aber…

Pfizer, Astellas win China nod for Padcev in bladder cancer with Merck’s Keytruda

…

Merck Aktie: Stabiles Wachstum zu fairem Preis

Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in einer…

Merck Market-Perform

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Merck KGaA auf "Market-Perform" mit einem Kursziel…

Merck führt erste cyber-physische Digital-Trust-Plattform für höhere Produktsicherheit und Schutz vor Produktfälschung am Markt ein

Merck: Darmstadt, Deutschland (ots/PRNewswire) - - Sichere cyber-physische Plattform M-Trust™ für vertrauenswürdigen digitalen Datenaustausch ermöglicht Erstellung digitaler Zwillinge zur Erhöhung…

Bernstein belässt Merck KGaA auf Market-Perform - Ziel 168 Euro

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Merck KGaA auf "Market-Perform" mit einem Kursziel…

Merck to buy vaccine plant from WuXi Biologics: report

…

Why Viking Therapeutics Stock Plummeted by 24% in December

Viking Therapeutics (NASDAQ: VKTX) didnt exactly capture investors hearts in the final month of 2024. The biotech companys share price…

Prediction: These 3 Healthcare Stocks Will Soar in 2025

No one knows for sure what the new year will hold for the market. However, some stocks chances for success…

Merck KGaA Aktie: Gewinn steigt kontinuierlich!

Die Merck-Aktie zeigt sich zum Jahresstart 2025 weitgehend stabil, mit geringfügigen Kursschwankungen im Bereich von 140 Euro. Im Tagesverlauf bewegte…

Should You Buy the Dip on This High-Flying Stock?

Its been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results,…

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…

Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks.

Investing in dividend stocks can be an excellent way to boost your income each year. But the challenge can be…

2 High-Yield Dividend Stocks to Buy Early in 2025

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb…

Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?

Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to…

3 Stocks That Could Be Monster Winners in 2025

What do many kids like most about the coming of a new year? The fireworks. Investors dont mind seeing some…

These stocks will be the biggest Dow winners of 2025, according to analysts

Some favorites of the Dow Jones Industrial Average, including Nvidia and Merck, could surge next year.…

2 Reasons to Sell Merck Stock and 1 Reason to Buy

There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner…

Merck - Selten so attraktiv

Mit strategischen Zukäufen treibt die deutsche Merck ihr geplantes Wachstum zielgerichtet voran. Die Anleger zeigen sich zuletzt aber skeptisch -…

Is Merck the Next Big Weight-Loss Stock?

Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the…

Is Recursion Pharmaceuticals Stock a Millionaire Maker?

Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a…

Merck Aktie: Aussichten trüb

Die Merck KGaA verzeichnet in den letzten Handelstagen des Jahres 2024 eine deutliche Abwärtsbewegung an der Frankfurter Börse. Der Pharma-…

Why Viking Therapeutics Tumbled by More Than 10% This Week

News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a…

BMO cuts rating on Merck and Biogen, on lack of near term catalyst By Investing.com

BMO cuts rating on Merck and Biogen, on lack of near term catalyst…

Investing in Merck (NYSE:MRK) three years ago would have delivered you a 43% gain

It hasnt been the best quarter for Merck & Co., Inc. ( NYSE:MRK ) shareholders, since the share price has…

Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks

Collecting dividend income on a recurring basis can help strengthen your financial position and be a way for you to…

Is Moderna Stock a Buy?

Modernas (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The companys revenue, earnings, and stock price…

Where Will Summit Therapeutics Be in 5 Years?

Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab,…

3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly…

MRKs Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals

Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1…

Mercks HIV treatment meets main goal of two late-stage studies By Reuters

Mercks HIV treatment meets main goal of two late-stage studies…

Merck Enters Obesity Space, Buys Rights to Hansohs Oral GLP-1 Drug

Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh Pharma.…

Opening Bell: Dow Jones steigt vor Zinsentscheid; Nvidia, Rigetti, IBM, D-Wave, Merck, Unitedhealth im Fokus

Am US-Aktienmarkt zeichnen sich am Mittwoch zum Handelsstart moderate Gewinne ab. Im Fokus steht die Leitzinsentscheidung zwei Stunden vor Börsenschluss…

Pharmaindustrie: Merck sichert sich Rechte an Abnehmpille in Milliardendeal

Der Pharmakonzern hat eine Lizenzvereinbarung mit dem chinesischem Biotech-Unternehmen Hansoh geschlossen. Merck darf künftig die Abnehmpille der Chinesen vermarkten und…

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion…

Merck pens $2bn deal for obesity drug from China’s Hansoh

Merck & Co Inc (NYSE:MRK, ETR:6MK) has sought a potential weight loss drug candidate through a deal worth up to…

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isnt for the faint of heart. These stocks tend to be highly volatile because of…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

dpa-AFX ProFeed